Presence of severe or multiple risk factors for venous or arterial thrombosis, including: Inherited or acquired predisposition to venous or arterial thrombosis, such as activated protein C resistance, antithrombin-III deficiency, protein C deficiency, protein S deficiency, and antiphospholipid antibodies (e.g., anticardiolipin antibodies or lupus anticoagulant)
The generic name is Semaglutide and this is the same molecule that has been previously only been available as a once weekly injection called Ozempic
This activation slows gastric motility, delays nutrient absorption, and enhances insulin secretion in response to meals
There may be a more affordable way to pay for your GLP-1 medication
The term wasnt widely discussed before TRIUMPH-4 reported in December 2025
Overall, we want to ensure that all people with medical conditions who could benefit from these medications have access to them, Dr